HOXB13 mutations and binding partners in prostate development and cancer: Function, clinical significance, and future directions

by Hannah Brechka, Raj R. Bhanvadia, Calvin VanOpstall, Donald J. Vander Griend
Published 2017-06-01

The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review

by Renee E. Vickman, Omar E. Franco, Daniel C. Moline, Donald J. Vander Griend, Praveen Thumbikat, Simon W. Hayward
Published 2020-07-01

Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signaling.

by Jason M D'Antonio, Donald J Vander Griend, Lizamma Antony, George Ndikuyeze, Susan L Dalrymple, Shahriar Koochekpour, John T Isaacs
Published 2010-07-01

MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans

by Calvin VanOpstall, Srikanth Perike, Hannah Brechka, Marc Gillard, Sophia Lamperis, Baizhen Zhu, Ryan Brown, Raj Bhanvadia, Donald J Vander Griend
Published 2020-06-01

Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer.

by Steven Kregel, Kyle J Kiriluk, Alex M Rosen, Yi Cai, Edwin E Reyes, Kristen B Otto, Westin Tom, Gladell P Paner, Russell Z Szmulewitz, Donald J Vander Griend
Published 2013-01-01

Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer

by Alfonso Urbanucci, Stefan J. Barfeld, Ville Kytölä, Harri M. Itkonen, Ilsa M. Coleman, Daniel Vodák, Liisa Sjöblom, Xia Sheng, Teemu Tolonen, Sarah Minner, Christoph Burdelski, Kati K. Kivinummi, Annika Kohvakka, Steven Kregel, Mandeep Takhar, Mohammed Alshalalfa, Elai Davicioni, Nicholas Erho, Paul Lloyd, R. Jeffrey Karnes, Ashley E. Ross, Edward M. Schaeffer, Donald J. Vander Griend, Stefan Knapp, Eva Corey, Felix Y. Feng, Peter S. Nelson, Fahri Saatcioglu, Karen E. Knudsen, Teuvo L.J. Tammela, Guido Sauter, Thorsten Schlomm, Matti Nykter, Tapio Visakorpi, Ian G. Mills
Published 2017-06-01